{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:40:38Z","timestamp":1793083238358,"version":"4.5.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/wco.0b013e328346c226","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T03:51:43Z","timestamp":1303789903000},"page":"291-299","source":"Crossref","is-referenced-by-count":83,"title":["Experimental models of multiple sclerosis"],"prefix":"10.1097","volume":"24","author":[{"given":"Andrew R","family":"Pachner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210206","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1750-3639.2007.00065.x","article-title":"Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis","volume":"17","author":"Rodriguez","year":"2007","journal-title":"Brain Pathol"},{"key":"R2-17-20210206","first-page":"193","article-title":"Remyelination in experimental models of toxin-induced demyelination","volume":"318","author":"Blakemore","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"R3-17-20210206","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1212\/WNL.37.4.550","article-title":"Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies","volume":"37","author":"Hemachudha","year":"1987","journal-title":"Neurology"},{"key":"R4-17-20210206","first-page":"217","article-title":"Induktion von Paralyse und Ruckenmarksentzundung durch Immunisierung von Kaninchen mit menschlichem Ruckenmarksgewebe","volume":"42","author":"Koritschoner","year":"1925","journal-title":"Z Immunitatsf Exp Ther"},{"key":"R5-17-20210206","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.58.1.39","article-title":"Observations on attempts to produce acute disseminated encephalomyelitis in monkeys","volume":"58","author":"Rivers","year":"1933","journal-title":"J Exp Med"},{"key":"R6-17-20210206","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1084\/jem.100.5.451","article-title":"A study of the chemical nature of components of bovine white matter effective in producing allergic encephalomyelitis in the rabbit","volume":"100","author":"Waksman","year":"1954","journal-title":"J Exp Med"},{"key":"R7-17-20210206","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"R8-17-20210206","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S1474-4422(04)00879-8","article-title":"Modelling of multiple sclerosis: lessons learned in a nonhuman primate","volume":"3","author":"'t Hart","year":"2004","journal-title":"Lancet Neurol"},{"key":"R9-17-20210206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1600-065x.2001.1830113.x","article-title":"Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus","volume":"183","author":"Genain","year":"2001","journal-title":"Immunol Rev"},{"key":"R10-17-20210206","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","article-title":"Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs","volume":"173","author":"Olson","year":"2004","journal-title":"J Immunol"},{"key":"R11-17-20210206","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.4049\/jimmunol.175.10.6303","article-title":"Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity","volume":"175","author":"Su","year":"2005","journal-title":"J Immunol"},{"key":"R12-17-20210206","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1242\/jcs.00378","article-title":"Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP","volume":"116","author":"Bruckener","year":"2003","journal-title":"J Cell Sci"},{"key":"R13-17-20210206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(93)90074-Z","article-title":"Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity","volume":"72","author":"Goverman","year":"1993","journal-title":"Cell"},{"key":"R14-17-20210206","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L","article-title":"Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein","volume":"32","author":"Lyons","year":"2002","journal-title":"Eur J Immunol"},{"key":"R15-17-20210206","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/glia.21026","article-title":"Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.","volume":"58","author":"Sasaki","year":"2010","journal-title":"Glia"},{"key":"R16-17-20210206","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-009-0177-0","article-title":"The blood\u2013brain and the blood\u2013cerebrospinal fluid barriers: function and dysfunction","volume":"31","author":"Engelhardt","year":"2009","journal-title":"Semin Immunopathol"},{"key":"R17-17-20210206","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0896-6273(00)81107-1","article-title":"Assessment of animal models for MS and demyelinating disease in the design of rational therapy","volume":"24","author":"Steinman","year":"1999","journal-title":"Neuron"},{"key":"R18-17-20210206","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/path.2476","article-title":"Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis","volume":"217","author":"Van Zwam","year":"2009","journal-title":"J Pathol"},{"key":"R19-17-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11940-008-0007-z","article-title":"Neuromyelitis optica","volume":"10","author":"Wingerchuk","year":"2008","journal-title":"Curr Treat Options Neurol"},{"key":"R20-17-20210206","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R21-17-20210206","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic antiaquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"R22-17-20210206","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"R23-17-20210206","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eji.1830110307","article-title":"The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis","volume":"11","author":"Ben-Nun","year":"1981","journal-title":"Eur J Immunol"},{"key":"R24-17-20210206","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature"},{"key":"R25-17-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-5728(93)90232-N","article-title":"Antiadhesion molecule therapy in experimental autoimmune encephalomyelitis","volume":"46","author":"Cannella","year":"1993","journal-title":"J Neuroimmunol"},{"key":"R26-17-20210206","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"R27-17-20210206","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann Neurol"},{"key":"R28-17-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jns.2008.06.032","article-title":"Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis","volume":"274","author":"Meinl","year":"2008","journal-title":"J Neurol Sci"},{"key":"R29-17-20210206","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archneurol.2010.99","article-title":"Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis","volume":"67","author":"Piccio","year":"2010","journal-title":"Arch Neurol"},{"key":"R30-17-20210206","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"R31-17-20210206","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann Neurol"},{"key":"R32-17-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"issue":"Suppl","key":"R33-17-20210206","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/ana.410360716","article-title":"McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion","volume":"36","author":"Raine","year":"1994","journal-title":"Ann Neurol"},{"key":"R34-17-20210206","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1084\/jem.172.4.1193","article-title":"An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis","volume":"172","author":"Ruddle","year":"1990","journal-title":"J Exp Med"},{"key":"R35-17-20210206","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ana.410300510","article-title":"Antitumor necrosis factor therapy abrogates autoimmune demyelination","volume":"30","author":"Selmaj","year":"1991","journal-title":"Ann Neurol"},{"key":"R36-17-20210206","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/WCO.0b013e3283391feb","article-title":"Cytokine networks in multiple sclerosis: lost in translation.","volume":"23","author":"Codarri","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"R37-17-20210206","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/intimm\/dxl080","article-title":"A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses","volume":"18","author":"Huntington","year":"2006","journal-title":"Int Immunol"},{"key":"R38-17-20210206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1750-3639.2001.tb00384.x","article-title":"Viral induced demyelination","volume":"11","author":"Stohlman","year":"2001","journal-title":"Brain Pathol"},{"key":"R39-17-20210206","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/IAI.15.3.903-909.1977","article-title":"Contrasting effects of immunosuppression on Theiler's virus infection in mice","volume":"15","author":"Lipton","year":"1977","journal-title":"Infect Immun"},{"key":"R40-17-20210206","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/brain\/123.3.519","article-title":"Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis","volume":"123","author":"McGavern","year":"2000","journal-title":"Brain"},{"key":"R41-17-20210206","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1128\/JVI.78.22.12480-12488.2004","article-title":"Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease","volume":"78","author":"Trottier","year":"2004","journal-title":"J Virol"},{"key":"R42-17-20210206","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2007.09.001","article-title":"Antibody-secreting cells in the central nervous system in an animal model of MS: phenotype, association with disability, and in vitro production of antibody","volume":"190","author":"Pachner","year":"2007","journal-title":"J Neuroimmunol"},{"key":"R43-17-20210206","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2007.01.017","article-title":"Intrathecal antibody production in an animal model of multiple sclerosis","volume":"185","author":"Pachner","year":"2007","journal-title":"J Neuroimmunol"},{"key":"R44-17-20210206","first-page":"626","article-title":"Primary demyelination in Theiler's virus infection. An ultrastructural study","volume":"33","author":"Dal Canto","year":"1975","journal-title":"Lab Invest"},{"key":"R45-17-20210206","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2010.09.026","article-title":"Plasma cells in the central nervous system in the Theilers virus model of multiple sclerosis.","volume":"232","author":"Pachner","year":"2011","journal-title":"J Neuroimmunol"},{"key":"R46-17-20210206","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.virusres.2005.04.010","article-title":"Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes","volume":"111","author":"Lipton","year":"2005","journal-title":"Virus Res"},{"key":"R47-17-20210206","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00401-004-0958-4","article-title":"Demyelination in canine distemper virus infection: a review","volume":"109","author":"Vandevelde","year":"2005","journal-title":"Acta Neuropathol"},{"key":"R48-17-20210206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/rmv.526","article-title":"Involvement of morbilliviruses in the pathogenesis of demyelinating disease","volume":"17","author":"Sips","year":"2007","journal-title":"Rev Med Virol"},{"key":"R49-17-20210206","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1022527628192","article-title":"Demyelinating disease: evolution of a paradigm","volume":"24","author":"Waksman","year":"1999","journal-title":"Neurochem Res"},{"key":"R50-17-20210206","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","volume":"343","author":"Confavreux","year":"2000","journal-title":"N Engl J Med"},{"key":"R51-17-20210206","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awq118","article-title":"The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability.","volume":"133","author":"Scalfari","year":"2010","journal-title":"Brain"},{"key":"R52-17-20210206","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann Neurol"},{"key":"R53-17-20210206","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study.","volume":"53","year":"1999","journal-title":"Neurology"},{"key":"R55-17-20210206","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14737175.9.3.319","article-title":"Why did IL-12\/IL-23 antibody therapy fail in multiple sclerosis?","volume":"9","author":"Longbrake","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"R56-17-20210206","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.20743","article-title":"Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis","volume":"58","author":"Sriram","year":"2005","journal-title":"Ann Neurol"},{"key":"R57-17-20210206","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awl083","article-title":"The value of animal models for drug development in multiple sclerosis","volume":"129","author":"Friese","year":"2006","journal-title":"Brain"},{"key":"R58-17-20210206","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pneurobio.2010.06.005","article-title":"Animal models of multiple sclerosis: potentials and limitations","volume":"92","author":"Mix","year":"2010","journal-title":"Prog Neurobiol"},{"key":"R59-17-20210206","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","article-title":"Update of the stroke therapy academic industry roundtable preclinical recommendations","volume":"40","author":"Fisher","year":"2009","journal-title":"Stroke"},{"key":"R60-17-20210206","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/STROKEAHA.107.498725","article-title":"Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach","volume":"39","author":"Crossley","year":"2008","journal-title":"Stroke"},{"key":"R61-17-20210206","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1026 experimental treatments in acute stroke","volume":"59","author":"O'Collins","year":"2006","journal-title":"Ann Neurol"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e328346c226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:23:43Z","timestamp":1786044223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-201106000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e328346c226","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}